Ista Investor Sues To Block $500M Bausch & Lomb Deal
An Ista Pharmaceuticals Inc. shareholder on Thursday challenged Bausch & Lomb Inc.'s $500 million bid for the eye care drug manufacturer in a class action alleging the offer is too low...To view the full article, register now.
Already a subscriber? Click here to view full article